Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FXNP5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $74,090
Award facts
- Contract value 100% obligated
- $74,089.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $74,089.92 for Cosentyx (secukinumab) 300mg dose in pre-filled pen format on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-competed delivery order represents a firm fixed price pharmaceutical supply contract, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, delivers this biologic medication to support Defense Health Agency and other military healthcare systems. Cosentyx, a specialty immunosuppressant used for autoimmune conditions, reflects the company's role in supplying brand-name specialty pharmaceuticals across multiple therapeutic domains. The delivery order demonstrates the operational efficiency of the DLA's pharmaceutical prime vendor model, which leverages framework agreements to fulfill routine medical supply needs through streamlined ordering processes rather than individual competitive solicitations.
Quick answers
Who was awarded contract SPE2DR26FXNP5?
SPE2DR26FXNP5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FXNP5 worth?
The government has obligated $74,090 on SPE2DR26FXNP5.
Is contract SPE2DR26FXNP5 an order under another contract?
Yes. SPE2DR26FXNP5 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNP5 competed?
The extent of competition for SPE2DR26FXNP5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award